Coronavirus: keenly awaited dexamethasone trial results confirm life-saving benefits – and risks

The keenly awaited full results from a British trial of the steroid dexamethasone were published on Friday, confirming its life-saving benefits for Covid-19 patients on ventilators but suggesting it may cause harm if given too early.A total of 2,104 hospitalised patients were assigned to receive six milligram daily doses of the medicine for up to 10 days, and 4,321 to receive usual care, with the rate of deaths compared after 28 days.Among patients on ventilators, the rate of death for patients…

Read the original article at South China Morning Post